Page 7 - Daptorum Group News Today

Good morning, investor! Let's close out the week right with a breakdown of the biggest pre-market stock movers for Friday!

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, is pleased to announce that the United States

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company focused on novel technologies including the targeting

Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group", the "Company"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global

These Hot Penny Stocks Continue to Spike As a Result of Reddit Traders Reddit penny stocks have become some of the hottest trending penny stocks to watch over the last year. If you’re unfamiliar, Reddit is a social media platform that allows individuals to form groups or Subreddits. These Subreddits are based on anything from cats to old cars and you guessed it, penny stocks. Popular investor Subreddits include the likes of r/WallStreetBets and r/RedditPennyStocks among others.  And wh...

Aptorum Group Limited to Present at The Benzinga Global Small Cap Conference Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced that Mr. Darren Lui, President and Executive Director of Aptorum Group, will present at the Benzinga Global Small Cap Conference. The Benzinga Global Small Cap Conference Date: Frida...

Aptorum Group Limited Interview to Air on Bloomberg Television U.S. on the RedChip Money Report Regulatory News: Aptorum Group Limited (Nasdaq: APM), a clinical-stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today announced an interview with President and Executive Director, Mr. Darren Lui, will air on The RedChip Money Report on the Bloomberg Network in the U.S. on Saturday, April 24 at 7 p.m. local time across the United States. T...

(0) Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, through its affiliate, has entered into a material transfer and option agreement ("Agreement") with Yale University ("Yale") to evaluate a group of preclinical stage novel immunomodulators. The novel immunomodulators may potentially target autoimmune and oncology diseases, including but not limited to, rheumatoid arthritis, lupus and sclerosis...